Triatomic Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$3.77M |
| 2 |
Kanzhun
BZ
|
+$1.56M |
| 3 |
Alibaba
BABA
|
+$1.47M |
| 4 |
Beyond Meat
BYND
|
+$1.29M |
| 5 |
GameStop
GME
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$3.73M |
| 2 |
Twilio
TWLO
|
+$3.63M |
| 3 |
Insulet
PODD
|
+$2.84M |
| 4 |
Guardant Health
GH
|
+$1.93M |
| 5 |
TSMC
TSM
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.38% |
| 2 | Healthcare | 21.11% |
| 3 | Communication Services | 5.98% |
| 4 | Consumer Discretionary | 5.77% |
| 5 | Technology | 2.57% |
Similar funds
Triatomic Management's Q2 2022 Portfolio in Review
As of Q2 2022, Triatomic Management held 54 positions worth $109M, down 12% from $123M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Triatomic Management withdrew a net $7.58M in Q2 2022, closing 11 positions and reducing 8 holdings. Its most notable exit was Palo Alto Networks, an estimated $3.73M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Triatomic Management opened a new position in Alphabet (Google) Class A worth $3.49M.
- Triatomic Management's largest Q2 2022 buy was Alphabet (Google) Class A: 32,000 shares worth $3.49M.
- Triatomic Management added most to Kanzhun in Q2 2022, an estimated $1.56M increase.
- Triatomic Management's biggest Q2 2022 reduction was Insulet, cutting an estimated $2.84M.
- Triatomic Management fully exited Palo Alto Networks in Q2 2022, selling an estimated $3.73M.
- Triatomic Management's ten largest holdings make up 74% of its $109M portfolio in Q2 2022.
- Triatomic Management opened 14 new positions and closed 11 in Q2 2022.
- Triatomic Management's portfolio value fell 12% quarter-over-quarter to $109M.
Based on Triatomic Management's 13F filing for Q2 2022, filed 12 Aug 2022.